Truvvo Partners’s Immunic IMUX Stock Holding History

Truvvo Partners’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,439	Closed	-$3.94M	–	49
2018 Q2	$3.94M	Hold	1,439	–	–	2.86%	9
2018 Q1	$3.91M	Hold	1,439	–	–	1.45%	18
2017 Q4	$3.42M	Hold	1,439	–	–	1.16%	20
2017 Q3	$2.91M	Hold	1,439	–	–	0.97%	27
2017 Q2	$1.67M	Hold	1,439	–	–	0.6%	41
2017 Q1	$2.3M	Hold	1,439	–	–	1.03%	23
2016 Q4	$2.5K	Hold	1,439	–	–	0.88%	24
2016 Q3	$3.52M	Hold	1,439	–	–	1.58%	16
2016 Q2	$3.57M	Hold	1,439	–	–	1.83%	11
2016 Q1	$5.22M	Hold	1,439	–	–	2.35%	9
2015 Q4	$6.63M	Buy	+1,439	New	+$4.7M	3.47%	6

Other funds holding IMUX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return